Name | N-[4-Nitro-3-(trifluoromethyl)phenyl]-(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methylpropanamide |
Synonyms | S4 S-4 Andarine S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide N-[4-Nitro-3-(trifluoromethyl)phenyl]-(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methylpropanamide (2R)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide |
CAS | 401900-40-1 |
InChI | InChI=1/C19H18F3N3O6/c1-11(26)23-12-3-6-14(7-4-12)31-10-18(2,28)17(27)24-13-5-8-16(25(29)30)15(9-13)19(20,21)22/h3-9,28H,10H2,1-2H3,(H,23,26)(H,24,27)/t18-/m1/s1 |
Molecular Formula | C19H18F3N3O6 |
Molar Mass | 441.36 |
Density | 1.472g/cm3 |
Boling Point | 698.735°C at 760 mmHg |
Flash Point | 376.381°C |
Solubility | DMSO ≥85mg/mL Water <1.2mg/mL Ethanol ≥85mg/mL |
Vapor Presure | 0mmHg at 25°C |
Storage Condition | -20℃ |
Refractive Index | 1.605 |
MDL | MFCD09027386 |
Use | An androgen receptor (AR) agonist with Ki of 4 nM. |